Global Prenatal Cell-Free DNA Screening Supply, Demand and Key Producers, 2026-2032
The global Prenatal Cell-Free DNA Screening market size is expected to reach $ 1444 million by 2032, rising at a market growth of 8.9% CAGR during the forecast period (2026-2032).
Prenatal Cell-Free DNA Screening refers to a prenatal screening approach that analyzes fetal genetic signals present as cell-free DNA fragments in a pregnant individual?s blood sample to estimate the risk of specific fetal genetic abnormalities without invasive procedures. The process involves standardized sample collection, laboratory analysis, computational interpretation, and structured clinical reporting, with results used to guide decisions about confirmatory diagnostic testing and ongoing prenatal care management. It is designed as a screening tool rather than a definitive diagnosis, and its clinical value depends on analytical accuracy, quality assurance, and responsible interpretation within established prenatal counseling and follow-up workflows.
Prenatal Cell-Free DNA Screening is now widely viewed as the most scalable pathway to bring DNA-based risk assessment into routine prenatal care, because it combines a noninvasive workflow with high-throughput laboratory operations and standardized reporting. From a research report perspective, the market is driven by continued substitution away from traditional serum-based screening, broader clinical acceptance of clear follow-up pathways, and ongoing improvements in bioinformatics and quality control that reduce test failures and strengthen performance in challenging samples. Competitive differentiation is increasingly defined by reliability at scale, analytical robustness under low fetal signal conditions, transparent clinical limitations, and the provider?s ability to integrate ordering, consent, reporting, and genetic counseling into a cohesive service model. At the same time, payer policy and regulatory scrutiny are shaping market structure, favoring providers that can demonstrate strong clinical validation, consistent end-to-end execution, and disciplined expansion of test scope without compromising interpretability or clinical governance.
This report studies the global Prenatal Cell-Free DNA Screening demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Prenatal Cell-Free DNA Screening, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prenatal Cell-Free DNA Screening that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Prenatal Cell-Free DNA Screening total market, 2021-2032, (USD Million)
Global Prenatal Cell-Free DNA Screening total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Prenatal Cell-Free DNA Screening total market, key domestic companies, and share, (USD Million)
Global Prenatal Cell-Free DNA Screening revenue by player, revenue and market share 2021-2026, (USD Million)
Global Prenatal Cell-Free DNA Screening total market by Type, CAGR, 2021-2032, (USD Million)
Global Prenatal Cell-Free DNA Screening total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Prenatal Cell-Free DNA Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Natera, Labcorp, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, SYNLAB, Myriad Genetics, GGA, Fulgent Genetics, BillionToOne, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Prenatal Cell-Free DNA Screening market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Prenatal Cell-Free DNA Screening Market, By Region:
1. How big is the global Prenatal Cell-Free DNA Screening market?
2. What is the demand of the global Prenatal Cell-Free DNA Screening market?
3. What is the year over year growth of the global Prenatal Cell-Free DNA Screening market?
4. What is the total value of the global Prenatal Cell-Free DNA Screening market?
5. Who are the Major Players in the global Prenatal Cell-Free DNA Screening market?
6. What are the growth factors driving the market demand?
Prenatal Cell-Free DNA Screening refers to a prenatal screening approach that analyzes fetal genetic signals present as cell-free DNA fragments in a pregnant individual?s blood sample to estimate the risk of specific fetal genetic abnormalities without invasive procedures. The process involves standardized sample collection, laboratory analysis, computational interpretation, and structured clinical reporting, with results used to guide decisions about confirmatory diagnostic testing and ongoing prenatal care management. It is designed as a screening tool rather than a definitive diagnosis, and its clinical value depends on analytical accuracy, quality assurance, and responsible interpretation within established prenatal counseling and follow-up workflows.
Prenatal Cell-Free DNA Screening is now widely viewed as the most scalable pathway to bring DNA-based risk assessment into routine prenatal care, because it combines a noninvasive workflow with high-throughput laboratory operations and standardized reporting. From a research report perspective, the market is driven by continued substitution away from traditional serum-based screening, broader clinical acceptance of clear follow-up pathways, and ongoing improvements in bioinformatics and quality control that reduce test failures and strengthen performance in challenging samples. Competitive differentiation is increasingly defined by reliability at scale, analytical robustness under low fetal signal conditions, transparent clinical limitations, and the provider?s ability to integrate ordering, consent, reporting, and genetic counseling into a cohesive service model. At the same time, payer policy and regulatory scrutiny are shaping market structure, favoring providers that can demonstrate strong clinical validation, consistent end-to-end execution, and disciplined expansion of test scope without compromising interpretability or clinical governance.
This report studies the global Prenatal Cell-Free DNA Screening demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Prenatal Cell-Free DNA Screening, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prenatal Cell-Free DNA Screening that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Prenatal Cell-Free DNA Screening total market, 2021-2032, (USD Million)
Global Prenatal Cell-Free DNA Screening total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Prenatal Cell-Free DNA Screening total market, key domestic companies, and share, (USD Million)
Global Prenatal Cell-Free DNA Screening revenue by player, revenue and market share 2021-2026, (USD Million)
Global Prenatal Cell-Free DNA Screening total market by Type, CAGR, 2021-2032, (USD Million)
Global Prenatal Cell-Free DNA Screening total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Prenatal Cell-Free DNA Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Natera, Labcorp, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, SYNLAB, Myriad Genetics, GGA, Fulgent Genetics, BillionToOne, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Prenatal Cell-Free DNA Screening market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Prenatal Cell-Free DNA Screening Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Core Condition Screening
- Expanded Condition Screening
- Whole Genome Sequencing
- Targeted Sequencing
- Others
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Natera
- Labcorp
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- SYNLAB
- Myriad Genetics
- GGA
- Fulgent Genetics
- BillionToOne
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
- Weihansi Biomedical Technology
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
1. How big is the global Prenatal Cell-Free DNA Screening market?
2. What is the demand of the global Prenatal Cell-Free DNA Screening market?
3. What is the year over year growth of the global Prenatal Cell-Free DNA Screening market?
4. What is the total value of the global Prenatal Cell-Free DNA Screening market?
5. Who are the Major Players in the global Prenatal Cell-Free DNA Screening market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Prenatal Cell-Free DNA Screening Introduction
1.2 World Prenatal Cell-Free DNA Screening Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Prenatal Cell-Free DNA Screening Total Market by Region (by Headquarter Location)
1.3.1 World Prenatal Cell-Free DNA Screening Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.3 China Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.4 Europe Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.5 Japan Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.6 South Korea Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.7 ASEAN Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.8 India Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Prenatal Cell-Free DNA Screening Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.2 World Prenatal Cell-Free DNA Screening Consumption Value by Region
2.2.1 World Prenatal Cell-Free DNA Screening Consumption Value by Region (2021-2026)
2.2.2 World Prenatal Cell-Free DNA Screening Consumption Value Forecast by Region (2027-2032)
2.3 United States Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.4 China Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.5 Europe Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.6 Japan Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.7 South Korea Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.8 ASEAN Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.9 India Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
3 WORLD PRENATAL CELL-FREE DNA SCREENING COMPANIES COMPETITIVE ANALYSIS
3.1 World Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Prenatal Cell-Free DNA Screening Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Prenatal Cell-Free DNA Screening in 2025
3.2.3 Global Concentration Ratios (CR8) for Prenatal Cell-Free DNA Screening in 2025
3.3 Prenatal Cell-Free DNA Screening Company Evaluation Quadrant
3.4 Prenatal Cell-Free DNA Screening Market: Overall Company Footprint Analysis
3.4.1 Prenatal Cell-Free DNA Screening Market: Region Footprint
3.4.2 Prenatal Cell-Free DNA Screening Market: Company Product Type Footprint
3.4.3 Prenatal Cell-Free DNA Screening Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Prenatal Cell-Free DNA Screening Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Prenatal Cell-Free DNA Screening Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Prenatal Cell-Free DNA Screening Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Prenatal Cell-Free DNA Screening Consumption Value Comparison
4.2.1 United States VS China: Prenatal Cell-Free DNA Screening Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Prenatal Cell-Free DNA Screening Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Prenatal Cell-Free DNA Screening Companies and Market Share, 2021-2026
4.3.1 United States Based Prenatal Cell-Free DNA Screening Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Prenatal Cell-Free DNA Screening Revenue, (2021-2026)
4.4 China Based Companies Prenatal Cell-Free DNA Screening Revenue and Market Share, 2021-2026
4.4.1 China Based Prenatal Cell-Free DNA Screening Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Prenatal Cell-Free DNA Screening Revenue, (2021-2026)
4.5 Rest of World Based Prenatal Cell-Free DNA Screening Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Prenatal Cell-Free DNA Screening Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Prenatal Cell-Free DNA Screening Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Prenatal Cell-Free DNA Screening Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Core Condition Screening
5.2.2 Expanded Condition Screening
5.3 Market Segment by Type
5.3.1 World Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
5.3.2 World Prenatal Cell-Free DNA Screening Market Size by Type (2027-2032)
5.3.3 World Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SEQUENCING METHOD
6.1 World Prenatal Cell-Free DNA Screening Market Size Overview by Sequencing Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sequencing Method
6.2.1 Whole Genome Sequencing
6.2.2 Targeted Sequencing
6.2.3 Others
6.3 Market Segment by Sequencing Method
6.3.1 World Prenatal Cell-Free DNA Screening Market Size by Sequencing Method (2021-2026)
6.3.2 World Prenatal Cell-Free DNA Screening Market Size by Sequencing Method (2027-2032)
6.3.3 World Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method (2027-2032)
7 MARKET ANALYSIS BY SERVICE MODEL
7.1 World Prenatal Cell-Free DNA Screening Market Size Overview by Service Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Model
7.2.1 Public Health Program
7.2.2 Consumer
7.2.3 Others
7.3 Market Segment by Service Model
7.3.1 World Prenatal Cell-Free DNA Screening Market Size by Service Model (2021-2026)
7.3.2 World Prenatal Cell-Free DNA Screening Market Size by Service Model (2027-2032)
7.3.3 World Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Prenatal Cell-Free DNA Screening Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Private Hospitals
8.3 Market Segment by Application
8.3.1 World Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
8.3.2 World Prenatal Cell-Free DNA Screening Market Size by Application (2027-2032)
8.3.3 World Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Natera
9.1.1 Natera Details
9.1.2 Natera Major Business
9.1.3 Natera Prenatal Cell-Free DNA Screening Product and Services
9.1.4 Natera Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Natera Recent Developments/Updates
9.1.6 Natera Competitive Strengths & Weaknesses
9.2 Labcorp
9.2.1 Labcorp Details
9.2.2 Labcorp Major Business
9.2.3 Labcorp Prenatal Cell-Free DNA Screening Product and Services
9.2.4 Labcorp Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Labcorp Recent Developments/Updates
9.2.6 Labcorp Competitive Strengths & Weaknesses
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Details
9.3.2 Quest Diagnostics Major Business
9.3.3 Quest Diagnostics Prenatal Cell-Free DNA Screening Product and Services
9.3.4 Quest Diagnostics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Quest Diagnostics Recent Developments/Updates
9.3.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.4 MedGenome
9.4.1 MedGenome Details
9.4.2 MedGenome Major Business
9.4.3 MedGenome Prenatal Cell-Free DNA Screening Product and Services
9.4.4 MedGenome Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MedGenome Recent Developments/Updates
9.4.6 MedGenome Competitive Strengths & Weaknesses
9.5 Mayo Clinic Laboratories
9.5.1 Mayo Clinic Laboratories Details
9.5.2 Mayo Clinic Laboratories Major Business
9.5.3 Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Product and Services
9.5.4 Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Mayo Clinic Laboratories Recent Developments/Updates
9.5.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
9.6 SYNLAB
9.6.1 SYNLAB Details
9.6.2 SYNLAB Major Business
9.6.3 SYNLAB Prenatal Cell-Free DNA Screening Product and Services
9.6.4 SYNLAB Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 SYNLAB Recent Developments/Updates
9.6.6 SYNLAB Competitive Strengths & Weaknesses
9.7 Myriad Genetics
9.7.1 Myriad Genetics Details
9.7.2 Myriad Genetics Major Business
9.7.3 Myriad Genetics Prenatal Cell-Free DNA Screening Product and Services
9.7.4 Myriad Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Myriad Genetics Recent Developments/Updates
9.7.6 Myriad Genetics Competitive Strengths & Weaknesses
9.8 GGA
9.8.1 GGA Details
9.8.2 GGA Major Business
9.8.3 GGA Prenatal Cell-Free DNA Screening Product and Services
9.8.4 GGA Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 GGA Recent Developments/Updates
9.8.6 GGA Competitive Strengths & Weaknesses
9.9 Fulgent Genetics
9.9.1 Fulgent Genetics Details
9.9.2 Fulgent Genetics Major Business
9.9.3 Fulgent Genetics Prenatal Cell-Free DNA Screening Product and Services
9.9.4 Fulgent Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Fulgent Genetics Recent Developments/Updates
9.9.6 Fulgent Genetics Competitive Strengths & Weaknesses
9.10 BillionToOne
9.10.1 BillionToOne Details
9.10.2 BillionToOne Major Business
9.10.3 BillionToOne Prenatal Cell-Free DNA Screening Product and Services
9.10.4 BillionToOne Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 BillionToOne Recent Developments/Updates
9.10.6 BillionToOne Competitive Strengths & Weaknesses
9.11 BGI Genomics
9.11.1 BGI Genomics Details
9.11.2 BGI Genomics Major Business
9.11.3 BGI Genomics Prenatal Cell-Free DNA Screening Product and Services
9.11.4 BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 BGI Genomics Recent Developments/Updates
9.11.6 BGI Genomics Competitive Strengths & Weaknesses
9.12 Berry Genomics
9.12.1 Berry Genomics Details
9.12.2 Berry Genomics Major Business
9.12.3 Berry Genomics Prenatal Cell-Free DNA Screening Product and Services
9.12.4 Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Berry Genomics Recent Developments/Updates
9.12.6 Berry Genomics Competitive Strengths & Weaknesses
9.13 Annaroad
9.13.1 Annaroad Details
9.13.2 Annaroad Major Business
9.13.3 Annaroad Prenatal Cell-Free DNA Screening Product and Services
9.13.4 Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Annaroad Recent Developments/Updates
9.13.6 Annaroad Competitive Strengths & Weaknesses
9.14 Genesky
9.14.1 Genesky Details
9.14.2 Genesky Major Business
9.14.3 Genesky Prenatal Cell-Free DNA Screening Product and Services
9.14.4 Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Genesky Recent Developments/Updates
9.14.6 Genesky Competitive Strengths & Weaknesses
9.15 Weihansi Biomedical Technology
9.15.1 Weihansi Biomedical Technology Details
9.15.2 Weihansi Biomedical Technology Major Business
9.15.3 Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Product and Services
9.15.4 Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Weihansi Biomedical Technology Recent Developments/Updates
9.15.6 Weihansi Biomedical Technology Competitive Strengths & Weaknesses
9.16 BGI Genomics
9.16.1 BGI Genomics Details
9.16.2 BGI Genomics Major Business
9.16.3 BGI Genomics Prenatal Cell-Free DNA Screening Product and Services
9.16.4 BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 BGI Genomics Recent Developments/Updates
9.16.6 BGI Genomics Competitive Strengths & Weaknesses
9.17 Berry Genomics
9.17.1 Berry Genomics Details
9.17.2 Berry Genomics Major Business
9.17.3 Berry Genomics Prenatal Cell-Free DNA Screening Product and Services
9.17.4 Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Berry Genomics Recent Developments/Updates
9.17.6 Berry Genomics Competitive Strengths & Weaknesses
9.18 Annaroad
9.18.1 Annaroad Details
9.18.2 Annaroad Major Business
9.18.3 Annaroad Prenatal Cell-Free DNA Screening Product and Services
9.18.4 Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Annaroad Recent Developments/Updates
9.18.6 Annaroad Competitive Strengths & Weaknesses
9.19 Genesky
9.19.1 Genesky Details
9.19.2 Genesky Major Business
9.19.3 Genesky Prenatal Cell-Free DNA Screening Product and Services
9.19.4 Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Genesky Recent Developments/Updates
9.19.6 Genesky Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Prenatal Cell-Free DNA Screening Industry Chain
10.2 Prenatal Cell-Free DNA Screening Upstream Analysis
10.3 Prenatal Cell-Free DNA Screening Midstream Analysis
10.4 Prenatal Cell-Free DNA Screening Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Prenatal Cell-Free DNA Screening Introduction
1.2 World Prenatal Cell-Free DNA Screening Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Prenatal Cell-Free DNA Screening Total Market by Region (by Headquarter Location)
1.3.1 World Prenatal Cell-Free DNA Screening Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.3 China Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.4 Europe Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.5 Japan Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.6 South Korea Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.7 ASEAN Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.3.8 India Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Prenatal Cell-Free DNA Screening Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.2 World Prenatal Cell-Free DNA Screening Consumption Value by Region
2.2.1 World Prenatal Cell-Free DNA Screening Consumption Value by Region (2021-2026)
2.2.2 World Prenatal Cell-Free DNA Screening Consumption Value Forecast by Region (2027-2032)
2.3 United States Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.4 China Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.5 Europe Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.6 Japan Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.7 South Korea Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.8 ASEAN Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
2.9 India Prenatal Cell-Free DNA Screening Consumption Value (2021-2032)
3 WORLD PRENATAL CELL-FREE DNA SCREENING COMPANIES COMPETITIVE ANALYSIS
3.1 World Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Prenatal Cell-Free DNA Screening Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Prenatal Cell-Free DNA Screening in 2025
3.2.3 Global Concentration Ratios (CR8) for Prenatal Cell-Free DNA Screening in 2025
3.3 Prenatal Cell-Free DNA Screening Company Evaluation Quadrant
3.4 Prenatal Cell-Free DNA Screening Market: Overall Company Footprint Analysis
3.4.1 Prenatal Cell-Free DNA Screening Market: Region Footprint
3.4.2 Prenatal Cell-Free DNA Screening Market: Company Product Type Footprint
3.4.3 Prenatal Cell-Free DNA Screening Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Prenatal Cell-Free DNA Screening Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Prenatal Cell-Free DNA Screening Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Prenatal Cell-Free DNA Screening Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Prenatal Cell-Free DNA Screening Consumption Value Comparison
4.2.1 United States VS China: Prenatal Cell-Free DNA Screening Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Prenatal Cell-Free DNA Screening Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Prenatal Cell-Free DNA Screening Companies and Market Share, 2021-2026
4.3.1 United States Based Prenatal Cell-Free DNA Screening Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Prenatal Cell-Free DNA Screening Revenue, (2021-2026)
4.4 China Based Companies Prenatal Cell-Free DNA Screening Revenue and Market Share, 2021-2026
4.4.1 China Based Prenatal Cell-Free DNA Screening Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Prenatal Cell-Free DNA Screening Revenue, (2021-2026)
4.5 Rest of World Based Prenatal Cell-Free DNA Screening Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Prenatal Cell-Free DNA Screening Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Prenatal Cell-Free DNA Screening Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Prenatal Cell-Free DNA Screening Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Core Condition Screening
5.2.2 Expanded Condition Screening
5.3 Market Segment by Type
5.3.1 World Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
5.3.2 World Prenatal Cell-Free DNA Screening Market Size by Type (2027-2032)
5.3.3 World Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SEQUENCING METHOD
6.1 World Prenatal Cell-Free DNA Screening Market Size Overview by Sequencing Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sequencing Method
6.2.1 Whole Genome Sequencing
6.2.2 Targeted Sequencing
6.2.3 Others
6.3 Market Segment by Sequencing Method
6.3.1 World Prenatal Cell-Free DNA Screening Market Size by Sequencing Method (2021-2026)
6.3.2 World Prenatal Cell-Free DNA Screening Market Size by Sequencing Method (2027-2032)
6.3.3 World Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method (2027-2032)
7 MARKET ANALYSIS BY SERVICE MODEL
7.1 World Prenatal Cell-Free DNA Screening Market Size Overview by Service Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Model
7.2.1 Public Health Program
7.2.2 Consumer
7.2.3 Others
7.3 Market Segment by Service Model
7.3.1 World Prenatal Cell-Free DNA Screening Market Size by Service Model (2021-2026)
7.3.2 World Prenatal Cell-Free DNA Screening Market Size by Service Model (2027-2032)
7.3.3 World Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Prenatal Cell-Free DNA Screening Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Private Hospitals
8.3 Market Segment by Application
8.3.1 World Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
8.3.2 World Prenatal Cell-Free DNA Screening Market Size by Application (2027-2032)
8.3.3 World Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Natera
9.1.1 Natera Details
9.1.2 Natera Major Business
9.1.3 Natera Prenatal Cell-Free DNA Screening Product and Services
9.1.4 Natera Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Natera Recent Developments/Updates
9.1.6 Natera Competitive Strengths & Weaknesses
9.2 Labcorp
9.2.1 Labcorp Details
9.2.2 Labcorp Major Business
9.2.3 Labcorp Prenatal Cell-Free DNA Screening Product and Services
9.2.4 Labcorp Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Labcorp Recent Developments/Updates
9.2.6 Labcorp Competitive Strengths & Weaknesses
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Details
9.3.2 Quest Diagnostics Major Business
9.3.3 Quest Diagnostics Prenatal Cell-Free DNA Screening Product and Services
9.3.4 Quest Diagnostics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Quest Diagnostics Recent Developments/Updates
9.3.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.4 MedGenome
9.4.1 MedGenome Details
9.4.2 MedGenome Major Business
9.4.3 MedGenome Prenatal Cell-Free DNA Screening Product and Services
9.4.4 MedGenome Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MedGenome Recent Developments/Updates
9.4.6 MedGenome Competitive Strengths & Weaknesses
9.5 Mayo Clinic Laboratories
9.5.1 Mayo Clinic Laboratories Details
9.5.2 Mayo Clinic Laboratories Major Business
9.5.3 Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Product and Services
9.5.4 Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Mayo Clinic Laboratories Recent Developments/Updates
9.5.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
9.6 SYNLAB
9.6.1 SYNLAB Details
9.6.2 SYNLAB Major Business
9.6.3 SYNLAB Prenatal Cell-Free DNA Screening Product and Services
9.6.4 SYNLAB Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 SYNLAB Recent Developments/Updates
9.6.6 SYNLAB Competitive Strengths & Weaknesses
9.7 Myriad Genetics
9.7.1 Myriad Genetics Details
9.7.2 Myriad Genetics Major Business
9.7.3 Myriad Genetics Prenatal Cell-Free DNA Screening Product and Services
9.7.4 Myriad Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Myriad Genetics Recent Developments/Updates
9.7.6 Myriad Genetics Competitive Strengths & Weaknesses
9.8 GGA
9.8.1 GGA Details
9.8.2 GGA Major Business
9.8.3 GGA Prenatal Cell-Free DNA Screening Product and Services
9.8.4 GGA Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 GGA Recent Developments/Updates
9.8.6 GGA Competitive Strengths & Weaknesses
9.9 Fulgent Genetics
9.9.1 Fulgent Genetics Details
9.9.2 Fulgent Genetics Major Business
9.9.3 Fulgent Genetics Prenatal Cell-Free DNA Screening Product and Services
9.9.4 Fulgent Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Fulgent Genetics Recent Developments/Updates
9.9.6 Fulgent Genetics Competitive Strengths & Weaknesses
9.10 BillionToOne
9.10.1 BillionToOne Details
9.10.2 BillionToOne Major Business
9.10.3 BillionToOne Prenatal Cell-Free DNA Screening Product and Services
9.10.4 BillionToOne Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 BillionToOne Recent Developments/Updates
9.10.6 BillionToOne Competitive Strengths & Weaknesses
9.11 BGI Genomics
9.11.1 BGI Genomics Details
9.11.2 BGI Genomics Major Business
9.11.3 BGI Genomics Prenatal Cell-Free DNA Screening Product and Services
9.11.4 BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 BGI Genomics Recent Developments/Updates
9.11.6 BGI Genomics Competitive Strengths & Weaknesses
9.12 Berry Genomics
9.12.1 Berry Genomics Details
9.12.2 Berry Genomics Major Business
9.12.3 Berry Genomics Prenatal Cell-Free DNA Screening Product and Services
9.12.4 Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Berry Genomics Recent Developments/Updates
9.12.6 Berry Genomics Competitive Strengths & Weaknesses
9.13 Annaroad
9.13.1 Annaroad Details
9.13.2 Annaroad Major Business
9.13.3 Annaroad Prenatal Cell-Free DNA Screening Product and Services
9.13.4 Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Annaroad Recent Developments/Updates
9.13.6 Annaroad Competitive Strengths & Weaknesses
9.14 Genesky
9.14.1 Genesky Details
9.14.2 Genesky Major Business
9.14.3 Genesky Prenatal Cell-Free DNA Screening Product and Services
9.14.4 Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Genesky Recent Developments/Updates
9.14.6 Genesky Competitive Strengths & Weaknesses
9.15 Weihansi Biomedical Technology
9.15.1 Weihansi Biomedical Technology Details
9.15.2 Weihansi Biomedical Technology Major Business
9.15.3 Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Product and Services
9.15.4 Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Weihansi Biomedical Technology Recent Developments/Updates
9.15.6 Weihansi Biomedical Technology Competitive Strengths & Weaknesses
9.16 BGI Genomics
9.16.1 BGI Genomics Details
9.16.2 BGI Genomics Major Business
9.16.3 BGI Genomics Prenatal Cell-Free DNA Screening Product and Services
9.16.4 BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 BGI Genomics Recent Developments/Updates
9.16.6 BGI Genomics Competitive Strengths & Weaknesses
9.17 Berry Genomics
9.17.1 Berry Genomics Details
9.17.2 Berry Genomics Major Business
9.17.3 Berry Genomics Prenatal Cell-Free DNA Screening Product and Services
9.17.4 Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Berry Genomics Recent Developments/Updates
9.17.6 Berry Genomics Competitive Strengths & Weaknesses
9.18 Annaroad
9.18.1 Annaroad Details
9.18.2 Annaroad Major Business
9.18.3 Annaroad Prenatal Cell-Free DNA Screening Product and Services
9.18.4 Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Annaroad Recent Developments/Updates
9.18.6 Annaroad Competitive Strengths & Weaknesses
9.19 Genesky
9.19.1 Genesky Details
9.19.2 Genesky Major Business
9.19.3 Genesky Prenatal Cell-Free DNA Screening Product and Services
9.19.4 Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Genesky Recent Developments/Updates
9.19.6 Genesky Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Prenatal Cell-Free DNA Screening Industry Chain
10.2 Prenatal Cell-Free DNA Screening Upstream Analysis
10.3 Prenatal Cell-Free DNA Screening Midstream Analysis
10.4 Prenatal Cell-Free DNA Screening Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Prenatal Cell-Free DNA Screening Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Prenatal Cell-Free DNA Screening Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Prenatal Cell-Free DNA Screening Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Prenatal Cell-Free DNA Screening Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Prenatal Cell-Free DNA Screening Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Prenatal Cell-Free DNA Screening Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Prenatal Cell-Free DNA Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Prenatal Cell-Free DNA Screening Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Prenatal Cell-Free DNA Screening Players in 2025
Table 12. World Prenatal Cell-Free DNA Screening Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Prenatal Cell-Free DNA Screening Company Evaluation Quadrant
Table 14. Head Office of Key Prenatal Cell-Free DNA Screening Players
Table 15. Prenatal Cell-Free DNA Screening Market: Company Product Type Footprint
Table 16. Prenatal Cell-Free DNA Screening Market: Company Product Application Footprint
Table 17. Prenatal Cell-Free DNA Screening Mergers & Acquisitions Activity
Table 18. United States VS China Prenatal Cell-Free DNA Screening Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Prenatal Cell-Free DNA Screening Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Prenatal Cell-Free DNA Screening Companies, Headquarters (States, Country)
Table 21. United States Based Companies Prenatal Cell-Free DNA Screening Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Prenatal Cell-Free DNA Screening Revenue Market Share (2021-2026)
Table 23. China Based Prenatal Cell-Free DNA Screening Companies, Headquarters (Province, Country)
Table 24. China Based Companies Prenatal Cell-Free DNA Screening Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Prenatal Cell-Free DNA Screening Revenue Market Share (2021-2026)
Table 26. Rest of World Based Prenatal Cell-Free DNA Screening Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Prenatal Cell-Free DNA Screening Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Prenatal Cell-Free DNA Screening Revenue Market Share (2021-2026)
Table 29. World Prenatal Cell-Free DNA Screening Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Prenatal Cell-Free DNA Screening Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Prenatal Cell-Free DNA Screening Market Size by Type (2027-2032) & (USD Million)
Table 32. World Prenatal Cell-Free DNA Screening Market Size by Sequencing Method, (USD Million), 2021 & 2025 & 2032
Table 33. World Prenatal Cell-Free DNA Screening Market Size Value by Sequencing Method (2021-2026) & (USD Million)
Table 34. World Prenatal Cell-Free DNA Screening Market Size by Sequencing Method (2027-2032) & (USD Million)
Table 35. World Prenatal Cell-Free DNA Screening Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Prenatal Cell-Free DNA Screening Market Size Value by Service Model (2021-2026) & (USD Million)
Table 37. World Prenatal Cell-Free DNA Screening Market Size by Service Model (2027-2032) & (USD Million)
Table 38. World Prenatal Cell-Free DNA Screening Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & (USD Million)
Table 40. World Prenatal Cell-Free DNA Screening Market Size by Application (2027-2032) & (USD Million)
Table 41. Natera Basic Information, Manufacturing Base and Competitors
Table 42. Natera Major Business
Table 43. Natera Prenatal Cell-Free DNA Screening Product and Services
Table 44. Natera Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Natera Recent Developments/Updates
Table 46. Natera Competitive Strengths & Weaknesses
Table 47. Labcorp Basic Information, Manufacturing Base and Competitors
Table 48. Labcorp Major Business
Table 49. Labcorp Prenatal Cell-Free DNA Screening Product and Services
Table 50. Labcorp Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Labcorp Recent Developments/Updates
Table 52. Labcorp Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Quest Diagnostics Major Business
Table 55. Quest Diagnostics Prenatal Cell-Free DNA Screening Product and Services
Table 56. Quest Diagnostics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
Table 59. MedGenome Basic Information, Manufacturing Base and Competitors
Table 60. MedGenome Major Business
Table 61. MedGenome Prenatal Cell-Free DNA Screening Product and Services
Table 62. MedGenome Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MedGenome Recent Developments/Updates
Table 64. MedGenome Competitive Strengths & Weaknesses
Table 65. Mayo Clinic Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Mayo Clinic Laboratories Major Business
Table 67. Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Product and Services
Table 68. Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Mayo Clinic Laboratories Recent Developments/Updates
Table 70. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 71. SYNLAB Basic Information, Manufacturing Base and Competitors
Table 72. SYNLAB Major Business
Table 73. SYNLAB Prenatal Cell-Free DNA Screening Product and Services
Table 74. SYNLAB Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. SYNLAB Recent Developments/Updates
Table 76. SYNLAB Competitive Strengths & Weaknesses
Table 77. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 78. Myriad Genetics Major Business
Table 79. Myriad Genetics Prenatal Cell-Free DNA Screening Product and Services
Table 80. Myriad Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Myriad Genetics Recent Developments/Updates
Table 82. Myriad Genetics Competitive Strengths & Weaknesses
Table 83. GGA Basic Information, Manufacturing Base and Competitors
Table 84. GGA Major Business
Table 85. GGA Prenatal Cell-Free DNA Screening Product and Services
Table 86. GGA Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. GGA Recent Developments/Updates
Table 88. GGA Competitive Strengths & Weaknesses
Table 89. Fulgent Genetics Basic Information, Manufacturing Base and Competitors
Table 90. Fulgent Genetics Major Business
Table 91. Fulgent Genetics Prenatal Cell-Free DNA Screening Product and Services
Table 92. Fulgent Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Fulgent Genetics Recent Developments/Updates
Table 94. Fulgent Genetics Competitive Strengths & Weaknesses
Table 95. BillionToOne Basic Information, Manufacturing Base and Competitors
Table 96. BillionToOne Major Business
Table 97. BillionToOne Prenatal Cell-Free DNA Screening Product and Services
Table 98. BillionToOne Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. BillionToOne Recent Developments/Updates
Table 100. BillionToOne Competitive Strengths & Weaknesses
Table 101. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 102. BGI Genomics Major Business
Table 103. BGI Genomics Prenatal Cell-Free DNA Screening Product and Services
Table 104. BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. BGI Genomics Recent Developments/Updates
Table 106. BGI Genomics Competitive Strengths & Weaknesses
Table 107. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 108. Berry Genomics Major Business
Table 109. Berry Genomics Prenatal Cell-Free DNA Screening Product and Services
Table 110. Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Berry Genomics Recent Developments/Updates
Table 112. Berry Genomics Competitive Strengths & Weaknesses
Table 113. Annaroad Basic Information, Manufacturing Base and Competitors
Table 114. Annaroad Major Business
Table 115. Annaroad Prenatal Cell-Free DNA Screening Product and Services
Table 116. Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Annaroad Recent Developments/Updates
Table 118. Annaroad Competitive Strengths & Weaknesses
Table 119. Genesky Basic Information, Manufacturing Base and Competitors
Table 120. Genesky Major Business
Table 121. Genesky Prenatal Cell-Free DNA Screening Product and Services
Table 122. Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Genesky Recent Developments/Updates
Table 124. Genesky Competitive Strengths & Weaknesses
Table 125. Weihansi Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 126. Weihansi Biomedical Technology Major Business
Table 127. Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Product and Services
Table 128. Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Weihansi Biomedical Technology Recent Developments/Updates
Table 130. Weihansi Biomedical Technology Competitive Strengths & Weaknesses
Table 131. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 132. BGI Genomics Major Business
Table 133. BGI Genomics Prenatal Cell-Free DNA Screening Product and Services
Table 134. BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. BGI Genomics Recent Developments/Updates
Table 136. BGI Genomics Competitive Strengths & Weaknesses
Table 137. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 138. Berry Genomics Major Business
Table 139. Berry Genomics Prenatal Cell-Free DNA Screening Product and Services
Table 140. Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Berry Genomics Recent Developments/Updates
Table 142. Berry Genomics Competitive Strengths & Weaknesses
Table 143. Annaroad Basic Information, Manufacturing Base and Competitors
Table 144. Annaroad Major Business
Table 145. Annaroad Prenatal Cell-Free DNA Screening Product and Services
Table 146. Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Annaroad Recent Developments/Updates
Table 148. Annaroad Competitive Strengths & Weaknesses
Table 149. Genesky Basic Information, Manufacturing Base and Competitors
Table 150. Genesky Major Business
Table 151. Genesky Prenatal Cell-Free DNA Screening Product and Services
Table 152. Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Genesky Recent Developments/Updates
Table 154. Genesky Competitive Strengths & Weaknesses
Table 155. Global Key Players of Prenatal Cell-Free DNA Screening Upstream (Raw Materials)
Table 156. Global Prenatal Cell-Free DNA Screening Typical Customers
Table 1. World Prenatal Cell-Free DNA Screening Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Prenatal Cell-Free DNA Screening Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Prenatal Cell-Free DNA Screening Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Prenatal Cell-Free DNA Screening Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Prenatal Cell-Free DNA Screening Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Prenatal Cell-Free DNA Screening Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Prenatal Cell-Free DNA Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Prenatal Cell-Free DNA Screening Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Prenatal Cell-Free DNA Screening Players in 2025
Table 12. World Prenatal Cell-Free DNA Screening Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Prenatal Cell-Free DNA Screening Company Evaluation Quadrant
Table 14. Head Office of Key Prenatal Cell-Free DNA Screening Players
Table 15. Prenatal Cell-Free DNA Screening Market: Company Product Type Footprint
Table 16. Prenatal Cell-Free DNA Screening Market: Company Product Application Footprint
Table 17. Prenatal Cell-Free DNA Screening Mergers & Acquisitions Activity
Table 18. United States VS China Prenatal Cell-Free DNA Screening Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Prenatal Cell-Free DNA Screening Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Prenatal Cell-Free DNA Screening Companies, Headquarters (States, Country)
Table 21. United States Based Companies Prenatal Cell-Free DNA Screening Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Prenatal Cell-Free DNA Screening Revenue Market Share (2021-2026)
Table 23. China Based Prenatal Cell-Free DNA Screening Companies, Headquarters (Province, Country)
Table 24. China Based Companies Prenatal Cell-Free DNA Screening Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Prenatal Cell-Free DNA Screening Revenue Market Share (2021-2026)
Table 26. Rest of World Based Prenatal Cell-Free DNA Screening Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Prenatal Cell-Free DNA Screening Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Prenatal Cell-Free DNA Screening Revenue Market Share (2021-2026)
Table 29. World Prenatal Cell-Free DNA Screening Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Prenatal Cell-Free DNA Screening Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Prenatal Cell-Free DNA Screening Market Size by Type (2027-2032) & (USD Million)
Table 32. World Prenatal Cell-Free DNA Screening Market Size by Sequencing Method, (USD Million), 2021 & 2025 & 2032
Table 33. World Prenatal Cell-Free DNA Screening Market Size Value by Sequencing Method (2021-2026) & (USD Million)
Table 34. World Prenatal Cell-Free DNA Screening Market Size by Sequencing Method (2027-2032) & (USD Million)
Table 35. World Prenatal Cell-Free DNA Screening Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Prenatal Cell-Free DNA Screening Market Size Value by Service Model (2021-2026) & (USD Million)
Table 37. World Prenatal Cell-Free DNA Screening Market Size by Service Model (2027-2032) & (USD Million)
Table 38. World Prenatal Cell-Free DNA Screening Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & (USD Million)
Table 40. World Prenatal Cell-Free DNA Screening Market Size by Application (2027-2032) & (USD Million)
Table 41. Natera Basic Information, Manufacturing Base and Competitors
Table 42. Natera Major Business
Table 43. Natera Prenatal Cell-Free DNA Screening Product and Services
Table 44. Natera Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Natera Recent Developments/Updates
Table 46. Natera Competitive Strengths & Weaknesses
Table 47. Labcorp Basic Information, Manufacturing Base and Competitors
Table 48. Labcorp Major Business
Table 49. Labcorp Prenatal Cell-Free DNA Screening Product and Services
Table 50. Labcorp Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Labcorp Recent Developments/Updates
Table 52. Labcorp Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Quest Diagnostics Major Business
Table 55. Quest Diagnostics Prenatal Cell-Free DNA Screening Product and Services
Table 56. Quest Diagnostics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
Table 59. MedGenome Basic Information, Manufacturing Base and Competitors
Table 60. MedGenome Major Business
Table 61. MedGenome Prenatal Cell-Free DNA Screening Product and Services
Table 62. MedGenome Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MedGenome Recent Developments/Updates
Table 64. MedGenome Competitive Strengths & Weaknesses
Table 65. Mayo Clinic Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Mayo Clinic Laboratories Major Business
Table 67. Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Product and Services
Table 68. Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Mayo Clinic Laboratories Recent Developments/Updates
Table 70. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 71. SYNLAB Basic Information, Manufacturing Base and Competitors
Table 72. SYNLAB Major Business
Table 73. SYNLAB Prenatal Cell-Free DNA Screening Product and Services
Table 74. SYNLAB Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. SYNLAB Recent Developments/Updates
Table 76. SYNLAB Competitive Strengths & Weaknesses
Table 77. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 78. Myriad Genetics Major Business
Table 79. Myriad Genetics Prenatal Cell-Free DNA Screening Product and Services
Table 80. Myriad Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Myriad Genetics Recent Developments/Updates
Table 82. Myriad Genetics Competitive Strengths & Weaknesses
Table 83. GGA Basic Information, Manufacturing Base and Competitors
Table 84. GGA Major Business
Table 85. GGA Prenatal Cell-Free DNA Screening Product and Services
Table 86. GGA Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. GGA Recent Developments/Updates
Table 88. GGA Competitive Strengths & Weaknesses
Table 89. Fulgent Genetics Basic Information, Manufacturing Base and Competitors
Table 90. Fulgent Genetics Major Business
Table 91. Fulgent Genetics Prenatal Cell-Free DNA Screening Product and Services
Table 92. Fulgent Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Fulgent Genetics Recent Developments/Updates
Table 94. Fulgent Genetics Competitive Strengths & Weaknesses
Table 95. BillionToOne Basic Information, Manufacturing Base and Competitors
Table 96. BillionToOne Major Business
Table 97. BillionToOne Prenatal Cell-Free DNA Screening Product and Services
Table 98. BillionToOne Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. BillionToOne Recent Developments/Updates
Table 100. BillionToOne Competitive Strengths & Weaknesses
Table 101. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 102. BGI Genomics Major Business
Table 103. BGI Genomics Prenatal Cell-Free DNA Screening Product and Services
Table 104. BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. BGI Genomics Recent Developments/Updates
Table 106. BGI Genomics Competitive Strengths & Weaknesses
Table 107. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 108. Berry Genomics Major Business
Table 109. Berry Genomics Prenatal Cell-Free DNA Screening Product and Services
Table 110. Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Berry Genomics Recent Developments/Updates
Table 112. Berry Genomics Competitive Strengths & Weaknesses
Table 113. Annaroad Basic Information, Manufacturing Base and Competitors
Table 114. Annaroad Major Business
Table 115. Annaroad Prenatal Cell-Free DNA Screening Product and Services
Table 116. Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Annaroad Recent Developments/Updates
Table 118. Annaroad Competitive Strengths & Weaknesses
Table 119. Genesky Basic Information, Manufacturing Base and Competitors
Table 120. Genesky Major Business
Table 121. Genesky Prenatal Cell-Free DNA Screening Product and Services
Table 122. Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Genesky Recent Developments/Updates
Table 124. Genesky Competitive Strengths & Weaknesses
Table 125. Weihansi Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 126. Weihansi Biomedical Technology Major Business
Table 127. Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Product and Services
Table 128. Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Weihansi Biomedical Technology Recent Developments/Updates
Table 130. Weihansi Biomedical Technology Competitive Strengths & Weaknesses
Table 131. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 132. BGI Genomics Major Business
Table 133. BGI Genomics Prenatal Cell-Free DNA Screening Product and Services
Table 134. BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. BGI Genomics Recent Developments/Updates
Table 136. BGI Genomics Competitive Strengths & Weaknesses
Table 137. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 138. Berry Genomics Major Business
Table 139. Berry Genomics Prenatal Cell-Free DNA Screening Product and Services
Table 140. Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Berry Genomics Recent Developments/Updates
Table 142. Berry Genomics Competitive Strengths & Weaknesses
Table 143. Annaroad Basic Information, Manufacturing Base and Competitors
Table 144. Annaroad Major Business
Table 145. Annaroad Prenatal Cell-Free DNA Screening Product and Services
Table 146. Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Annaroad Recent Developments/Updates
Table 148. Annaroad Competitive Strengths & Weaknesses
Table 149. Genesky Basic Information, Manufacturing Base and Competitors
Table 150. Genesky Major Business
Table 151. Genesky Prenatal Cell-Free DNA Screening Product and Services
Table 152. Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Genesky Recent Developments/Updates
Table 154. Genesky Competitive Strengths & Weaknesses
Table 155. Global Key Players of Prenatal Cell-Free DNA Screening Upstream (Raw Materials)
Table 156. Global Prenatal Cell-Free DNA Screening Typical Customers
LIST OF FIGURES
Figure 1. Prenatal Cell-Free DNA Screening Picture
Figure 2. World Prenatal Cell-Free DNA Screening Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Prenatal Cell-Free DNA Screening Total Revenue (2021-2032) & (USD Million)
Figure 4. World Prenatal Cell-Free DNA Screening Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Prenatal Cell-Free DNA Screening Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 13. Prenatal Cell-Free DNA Screening Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 16. World Prenatal Cell-Free DNA Screening Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 18. China Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 23. India Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Prenatal Cell-Free DNA Screening by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Prenatal Cell-Free DNA Screening Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Prenatal Cell-Free DNA Screening Markets in 2025
Figure 27. United States VS China: Prenatal Cell-Free DNA Screening Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Prenatal Cell-Free DNA Screening Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Prenatal Cell-Free DNA Screening Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Prenatal Cell-Free DNA Screening Market Size Market Share by Type in 2025
Figure 31. Core Condition Screening
Figure 32. Expanded Condition Screening
Figure 33. World Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2032)
Figure 34. World Prenatal Cell-Free DNA Screening Market Size by Sequencing Method, (USD Million), 2021 & 2025 & 2032
Figure 35. World Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method in 2025
Figure 36. Whole Genome Sequencing
Figure 37. Targeted Sequencing
Figure 38. Others
Figure 39. World Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method (2021-2032)
Figure 40. World Prenatal Cell-Free DNA Screening Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 41. World Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model in 2025
Figure 42. Public Health Program
Figure 43. Consumer
Figure 44. Others
Figure 45. World Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model (2021-2032)
Figure 46. World Prenatal Cell-Free DNA Screening Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Prenatal Cell-Free DNA Screening Market Size Market Share by Application in 2025
Figure 48. Public Hospitals
Figure 49. Private Hospitals
Figure 50. World Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2032)
Figure 51. Prenatal Cell-Free DNA Screening Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Prenatal Cell-Free DNA Screening Picture
Figure 2. World Prenatal Cell-Free DNA Screening Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Prenatal Cell-Free DNA Screening Total Revenue (2021-2032) & (USD Million)
Figure 4. World Prenatal Cell-Free DNA Screening Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Prenatal Cell-Free DNA Screening Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Prenatal Cell-Free DNA Screening Revenue (2021-2032) & (USD Million)
Figure 13. Prenatal Cell-Free DNA Screening Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 16. World Prenatal Cell-Free DNA Screening Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 18. China Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 23. India Prenatal Cell-Free DNA Screening Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Prenatal Cell-Free DNA Screening by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Prenatal Cell-Free DNA Screening Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Prenatal Cell-Free DNA Screening Markets in 2025
Figure 27. United States VS China: Prenatal Cell-Free DNA Screening Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Prenatal Cell-Free DNA Screening Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Prenatal Cell-Free DNA Screening Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Prenatal Cell-Free DNA Screening Market Size Market Share by Type in 2025
Figure 31. Core Condition Screening
Figure 32. Expanded Condition Screening
Figure 33. World Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2032)
Figure 34. World Prenatal Cell-Free DNA Screening Market Size by Sequencing Method, (USD Million), 2021 & 2025 & 2032
Figure 35. World Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method in 2025
Figure 36. Whole Genome Sequencing
Figure 37. Targeted Sequencing
Figure 38. Others
Figure 39. World Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method (2021-2032)
Figure 40. World Prenatal Cell-Free DNA Screening Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 41. World Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model in 2025
Figure 42. Public Health Program
Figure 43. Consumer
Figure 44. Others
Figure 45. World Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model (2021-2032)
Figure 46. World Prenatal Cell-Free DNA Screening Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Prenatal Cell-Free DNA Screening Market Size Market Share by Application in 2025
Figure 48. Public Hospitals
Figure 49. Private Hospitals
Figure 50. World Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2032)
Figure 51. Prenatal Cell-Free DNA Screening Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
